Market Place
Sourcing Support
CRISPR Ex Vivo Gene Editing Gets on Target With Caribou’s Hybrid
14 Oct 2024 //
BIOSPACE
Caribou Cuts NK Cell Program, Focuses On CAR-T Priorities
17 Jul 2024 //
FIERCE BIOTECH
Caribou Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results
11 Mar 2024 //
PRESS RELEASE
Caribou Biosciences to Present Preclinical Data on CB-012
05 Mar 2024 //
PRESS RELEASE
Precision Announces Non-Exclusive Patent License Agreement with Caribou
20 Feb 2024 //
BUSINESSWIRE
AbbVie Terminates Caribou CAR-T Contract in Culling of Cancer Pipeline
28 Sep 2023 //
BIOSPACE
Caribou Biosciences Announces Pricing of Upsized $125 Million Public Offering
13 Jul 2023 //
PRESS RELEASE
Caribou Biosciences Announces Proposed Public Offering of Common Stock
13 Jul 2023 //
PRESS RELEASE
Caribou Reports Positive Data from Phase 1 Trial in r/r B-NHL
13 Jul 2023 //
PRESS RELEASE
Caribou Biosciences Receives $25 Million Equity Investment from Pfizer
11 Jul 2023 //
BIOPHARM
Caribou Biosciences Announces $25 Million Equity Investment from Pfizer
06 Jul 2023 //
PRESS RELEASE
Caribou Biosciences reports data from non-Hodgkin lymphoma therapy trial
13 Dec 2022 //
CLINICALTRIALSARENA
Wave of FDA Fast Track Designations Sparks Renewed Interest in Biotech Sector
01 Dec 2022 //
BIONJ
Caribou Biosciences Announces FDA Clearance of IND Application for CB-011
21 Nov 2022 //
PRESS RELEASE
Caribou`s CAR-T hit by durability doubts as patients relapse
11 Jun 2022 //
FIERCEBIOTECH
Caribou Announces Webcast Conference Call to Highlight CB-010 ANTLER PI Data
01 Jun 2022 //
PRESS RELEASE
Caribou Biosciences Presents Data on chRDNA Genome-Editing Technology
16 May 2022 //
PRESS RELEASE
Caribou Biosciences Appoints David Johnson to its Board of Directors
12 May 2022 //
PRESS RELEASE
Caribou`s Lymphoma Candidate Shows 100% Response Rate In Early-Stage Study
12 May 2022 //
BENZINGA
Caribou ready to uncork the chardonnay with early phase 1 data
12 May 2022 //
FIERCEBIOTECH
Caribou Biosciences Reports First Quarter 2022 Financial Results
09 May 2022 //
PRESS RELEASE
Caribou Biosciences to Present at Upcoming Investor Conference
03 May 2022 //
PRESS RELEASE
Caribou Biosciences Announces Presentation of chRDNA Platform Data
02 May 2022 //
PRESS RELEASE
Caribou to Share CB-010 Initial Clinical Data at the Upcoming (EHA) 2022
25 Apr 2022 //
GLOBENEWSWIRE
Caribou Bio to Present at SVB Leerink 11th Annual Global HC Conference
07 Feb 2022 //
PRESS RELEASE
Caribou Biosciences data highlights benefits of CRISPR hybrid RNA-DNA guide tech
02 Sep 2021 //
SEEKING ALPHA
Caribou Biosciences Announces Closing of Upsized Initial Public Offering
29 Jul 2021 //
BUSINESSWIRE
Caribou Biosciences Announces Closing of Upsized Initial Public Offering
27 Jul 2021 //
PR NEWSWIRE
Caribou gives back early gains after pricing $304M IPO
26 Jul 2021 //
BIOCENTURY
Caribou Biosciences Announces Pricing of Upsized Initial Public Offering
23 Jul 2021 //
BUSINESSWIRE
Caribou grabs $304M IPO to herd off-the-shelf CAR-Ts into clinic
23 Jul 2021 //
FIERCEBIOTECH
Caribou Doses First Patient in Phase 1 Clinical Trial Evaluating CB-010
12 Jul 2021 //
BUSINESSWIRE
Caribou Raises $115M Series C Financing to Advance Next-Generation CRISPR
03 Mar 2021 //
BUSINESSWIRE
Doudna-founded biotech Caribou raises fresh funds to fuel gene editing pipeline
03 Mar 2021 //
BIOPHARMADIVE
AbbVie to Collaborate with Caribou Biosciences on CAR-T Cell Therapeutics
10 Feb 2021 //
PHARMTECH
Caribou Biosciences Appoints Jason O’Byrne as Chief Financial Officer
09 Feb 2021 //
BUSINESSWIRE
Caribou Biosciences Announces Licensing Agreement for scFvs Targeting CD371
18 Nov 2020 //
YAHOO
Caribou Biosciences Co-Founder Dr. Jennifer Doudna Awarded Nobel Prize Chemistry
07 Oct 2020 //
BUSINESSWIRE
